Prognostic impact of the 21-gene recurrence score (RS) on disease-free and overall survival of node-positive, ER-positive breast cancer patients (pts) treated with adjuvant chemotherapy: Results from NSABP B-28.
Eleftherios P. Mamounas
Consultant or Advisory Role - Genomic Health
Honoraria - Genomic Health
Gong Tang
No relevant relationships to disclose
Soonmyung Paik
No relevant relationships to disclose
Frederick L. Baehner
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Qing Liu
No relevant relationships to disclose
Jong-Hyeon Jeong
No relevant relationships to disclose
Seong-Rim Kim
No relevant relationships to disclose
Steven M Butler
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Farid Jamshidian
Employment or Leadership Position - Genomic Health
Diana B. Cherbavaz
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Steven Shak
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Thomas B. Julian
No relevant relationships to disclose
Barry C. Lembersky
Stock Ownership - Genomic Health
D. Lawrence Wickerham
No relevant relationships to disclose
Joseph P. Costantino
No relevant relationships to disclose
Norman Wolmark
No relevant relationships to disclose